What is Novateor Research Laboratories share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Novateor Research Laboratories?

The latest standalone P/E ratio of Novateor Research Laboratories as of 16-Sep-2024 is 902.95.

What is the P/B ratio of Novateor Research Laboratories?

The latest standalone P/B ratio of Novateor Research Laboratories as of 16-Sep-2024 is 3.35.

What is the 52-week high and low of Novateor Research Laboratories?

The 52-week high of Novateor Research Laboratories is Rs. 56.85 and the 52-week low is Rs. 27.95.

Novateor Research Laboratories Ltd - Stock Valuation and Financial Performance

Name: Novateor Research Laboratories
Brand: Novateor Research Laboratories

BSE: 542771 | NSE: | Household & Personal Products | Small Cap

Place order

Novateor Research Share Price

₹52.30 0.00 0.00%
as on 16-Sep'24 16:01

DeciZen - make an informed investing decision on Novateor Research

Based on:

Data

M-Cap below 100cr DeciZen not available

Novateor Research Laboratories stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

902.95

Market Cap:

25.3 Cr.

52-wk low:

52-wk high:

56.9

Is Novateor Research Laboratories Ltd an attractive stock to invest in?

1. Is Novateor Research Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Novateor Research Laboratories Ltd is a below average quality company.

2. Is Novateor Research Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Novateor Research Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Novateor Research Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Novateor Research Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Novateor Research:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	0.8%	0.6%	11.9%	0.6%	0.2%	-3.3%	0.8%	-
Value Creation Index ⓘ	-0.9	-1.0	-0.2	-1.0	-1.0	-1.2	-0.9	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.1	0.1	0.4	0.4	0.2	0.7	1.3	1
Sales YoY Gr.	-	-35.7%	355.6%	-4.9%	-51.3%	289.5%	70.3%	-
Adj EPS ⓘ	-0.6	0.2	0.7	-0	0	-0.5	0.1	0.1
YoY Gr.	-	NA	311.1%	-102.7%	NA	-2450%	NA	-
BVPS (₹) ⓘ	186.5	186.7	11.1	15.7	15.8	15.4	15.6	15.6
Adj Net Profit ⓘ	0	0	0.2	0	0	-0.2	0	0
Cash Flow from Ops. ⓘ	0	0.1	-0.1	-3.4	-0.3	-1.4	-0.5	-
Debt/CF from Ops. ⓘ	110.3	15	-0.2	-0	-0.9	-0.2	-1.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	69.5%	47.8%	70.3%
Adj EPS ⓘ	NA	-15%	NA	NA
BVPSⓘ	NA	-39.2%	-0.2%	1%
Share Price	-	8.7%	77.9%	87.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	-0.3	0.1	8.7	-0.1	0.1	-2.8	0.5	0.4
Op. Profit Mgn % ⓘ	42.3	60.2	70.5	-34.9	-175.6	-88.6	-26.8	NAN
Net Profit Mgn % ⓘ	-2.2	1	53.6	-2	6.3	-30.8	2.9	2.4
Debt to Equity ⓘ	0.9	0.9	0	0	0	0	0.1	-
Working Cap Days ⓘ	0	939	428	2,397	9,015	2,572	1,743	0
Cash Conv. Cycle ⓘ	0	658	315	596	1,341	381	293	0

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 0.40%

Sales growth is growing at healthy rate in last 3 years 47.83%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Novateor Research Laboratories Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.1	-
TTM Sales (₹ Cr.)	1.2	-
BVPS (₹.) ⓘ	15.6	-
Reserves (₹ Cr.) ⓘ	3	-
P/BV ⓘ	3.35	-
PE ⓘ	902.95	-

From the Market
52 Week Low / High (₹)	27.95 / 56.85
All Time Low / High (₹)	3.23 / 56.85
Market Cap (₹ Cr.)	25.3
Equity (₹ Cr.)	4.8
Face Value (₹)	10
Industry PE ⓘ	66.4

Management X-Ray of Novateor Research:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Novateor Research

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Novateor Research

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0.14	0.09	0.41	0.39	0.19	0.74	1.26
Operating Expenses ⓘ	0.08	0.03	0.12	0.53	0.52	1.40	1.60
Manufacturing Costs	0	0	0	0	0	0.01	0.01
Material Costs	0.03	0.03	0.03	0.25	0.21	0.53	0.96
Employee Cost	0.02	0	0.02	0.16	0.13	0.22	0.39
Other Costs ⓘ	0.02	0.01	0.07	0.12	0.17	0.64	0.24
Operating Profit ⓘ	0.06	0.05	0.29	-0.14	-0.33	-0.66	-0.34
Operating Profit Margin (%)	42.3%	60.2%	70.5%	-34.9%	-175.0%	-88.6%	-26.8%
Other Income ⓘ	0.02	0.03	0.11	0.27	0.44	0.48	0.49
Interest ⓘ	0.01	0.01	0	0.01	0	0	0.03
Depreciation ⓘ	0.07	0.07	0.10	0.10	0.10	0.09	0.09
Exceptional Items ⓘ	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	0.30	0.03	0.02	-0.26	0.04
Tax ⓘ	0.01	0	0.08	0.03	0	-0.03	0
Profit After Tax	0	0	0.22	-0.01	0.01	-0.23	0.04
PAT Margin (%)	-2.2%	1.0%	53.6%	-2.0%	6.3%	-30.8%	2.9%
Adjusted EPS (₹)	0.0	0.0	0.7	0.0	0.0	-0.5	0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	0.93	0.93	4.08	8.56	8.57	7.84	7.88
Share Capital ⓘ	0.05	0.05	2.96	4.83	4.83	4.83	4.83
Reserves ⓘ	0.88	0.88	1.11	3.73	3.74	3.01	3.05
Minority Interest	0	0	0	0	0	0	0
Debt	0.87	0.82	0.01	0.14	0.24	0.24	0.86
Long Term Debt	0.84	0.82	0.01	0.14	0.24	0.24	0.68
Short Term Debt	0.03	0	0	0	0	0	0.18
Trade Payables	0.06	0.06	0.12	0.01	0.06	0.03	0.18
Others Liabilities ⓘ	0.04	0.04	0.10	0.08	0.10	0.03	-0.02
Total Liabilities ⓘ	1.90	1.84	4.32	8.79	8.97	8.14	8.90
Fixed Assets
Gross Block	1.72	1.72	3.78	3.78	3.78	2.31	2.33
Accumulated Depreciation	0.07	0.14	0.23	0.33	0.42	0.46	0.54
Net Fixed Assetsⓘ	1.66	1.59	3.55	3.45	3.36	1.86	1.78
CWIP ⓘ	0	0	0	0	0	0.09	0.43
Investmentsⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Inventories	0.12	0.15	0.53	0.48	0.49	0.50	0.56
Trade Receivables	0.07	0.06	0.15	0.25	0.20	0.43	0.70
Cash Equivalents	0	0.02	0.02	0.69	0.66	0.48	0.22
Others Assetsⓘ	0.04	0.01	0.05	3.92	4.26	4.78	5.19
Total Assets ⓘ	1.90	1.84	4.32	8.79	8.97	8.14	8.90

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0.01	0.05	-0.07	-3.42	-0.27	-1.38	-0.50
PBT ⓘ	0	0	0.30	0.03	0.01	-0.23	0.04
Adjustment ⓘ	0.08	0.08	0.10	0.10	0.13	0.12	0.15
Changes in Working Capital ⓘ	-0.07	-0.02	-0.39	-3.54	-0.4	-1.27	-0.68
Tax Paid ⓘ	0	0	-0.07	0	0	0	0
Cash Flow From Investing Activity ⓘ	-0.01	0	-1.96	-0.10	-0.09	1.51	0.30
Capex	-0.01	0	-1.96	-0.10	-0.09	1.51	0.30
Net Investments	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0	-0.03	2.03	4.18	0.32	-0.35	-0.06
Net Proceeds from Shares ⓘ	0	0	2.84	4.49	0	0	0
Net Proceeds from Borrowing ⓘ	0	-0.03	-0.80	-0.13	0.10	0.10	0.45
Interest Paid ⓘ	-0.01	-0.01	0	0.01	0.14	0.14	-0.06
Dividend Paid ⓘ	0	0	0	0	0	0	0
Others ⓘ	0.01	0	0	-0.19	0.08	-0.58	-0.44
Net Cash Flow ⓘ	-0.01	0.02	0	0.67	-0.04	-0.22	-0.25

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	-0.32	0.1	10.41	-0.15	0.16	-3.02	0.49
ROCE (%)	0.78	0.57	11.87	0.64	0.23	-3.33	0.83
Asset Turnover Ratio	0.07	0.05	0.13	0.06	0.02	0.09	0.15
PAT to CFO Conversion(x)	N/A	N/A	-0.32	N/A	-27	N/A	-12.5
Working Capital Days
Receivable Days	180	262	95	184	431	155	165
Inventory Days	331	575	306	466	936	243	154
Payable Days	752	852	1,114	98	61	30	40

Novateor Research Laboratories Ltd Stock News

Novateor Research Laboratories Ltd FAQs

What is the share price of Novateor Research?

Company share prices are keep on changing according to the market conditions. The closing price of Novateor Research on 16-Sep-2024 16:01 is ₹52.30.

What is the market cap of Novateor Research?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Sep-2024 16:01 the market cap of Novateor Research stood at ₹25.28.